Pharmacy
News
FDA approves drug for newly diagnosed MM
The US Food and Drug Administration (FDA) has expanded the existing indication for lenalidomide (Revlimid)—in combination with dexamethasone—to...
News
FDA issues documents on drug compounding
Photo by Rhoda Baer The US Food and Drug Administration (FDA) has issued 5 draft documents related to drug compounding and repackaging that aim...
News
NICE rejects pomalidomide as MM treatment
In a final draft guidance, the UK’s National Institute for Health and Care Excellence (NICE) has said it cannot recommend pomalidomide (Imnovid)...
News
Anticoagulant now available in US pharmacies
Photo by Rhoda Baer The oral factor Xa inhibitor edoxaban (Savaysa) is now available in US pharmacies, according to Daiichi Sankyo Company,...
News
Though costly, blood cancer drugs appear cost-effective
Photo by Bill Branson A new analysis indicates that certain high-cost therapies for hematologic malignancies provide reasonable value for money...
News
EC approves bortezomib for MCL
Photo courtesy of Millennium The European Commission (EC) has approved bortezomib (Velcade) in combination with rituximab, cyclophosphamide,...
News
Vaccine gets orphan designation for ATLL
The European Medicines Agency (EMA) has granted orphan drug designation for a therapeutic vaccine candidate known as THV02 to treat adult T-cell...
News
Product deemed breakthrough for beta-thalassemia major
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to LentiGlobin® BB305 for the treatment of transfusion-...
News
NICE gives conditional support for eculizumab
Credit: Globovision The UK’s National Institute for Health and Care Excellence (NICE) has issued a final guidance recommending eculizumab (...
News
FDA approves ibrutinib for WM
Credit: CDC The US Food and Drug Administration (FDA) has granted approval for ibrutinib (Imbruvica) as the first and only treatment for patients...
News
Drug on the fast track to treat HAE
within pancreatic tissue Credit: Louisa Howard The US Food and Drug Administration (FDA) has granted fast track designation for BCX4161, an oral...